Approval · Notice of Compliance 22002 · 2019
DIPROLENE: Notice of Compliance 22002
Issued March 25, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22002
- Date
- March 25, 2019
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to the product monograph following deletion of 60 mg lotion
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIPROLENE | Not yet assigned | — |
Medicinal ingredients
- BETAMETHASONE DIPROPIONATE 0.05 PER